Indications and uses
for temporary relief of occasional constipation and irregularity this product generally produces bowel movement in 6 to 12 hours
for temporary relief of occasional constipation and irregularity this product generally produces bowel movement in 6 to 12 hours
Bisacodyl (USP) 5 mg
Stimulant laxative
Do not use if you cannot swallow without chewing
■ stomach pain, nausea or vomiting
■ a sudden change in bowel habits that lasts more than 2
weeks
■ do not chew or crush tablet(s)
■ it may cause stomach discomfort, faintness and cramps
■ do not use within 1 hour after taking an antacid or milk
■ you have rectal bleeding or no bowel movement after
using this product. These could be signs of a serious
condition.
■ you need to use a laxative for more than 1 week
Ifpregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
Directions
| adults and children 12 years and over | 1 to 3 tablets in a single daily dose |
| children 6 to under 12 years of age | 1 tablet in a single daily dose |
| children under 6 years of age | ask a doctor |
Other information
■
each tablet contains: magnesium 5 mg
■ store at 20-25°C (68-77°F)
■ protect from excessive humidity
Acacia, anhydrous calcium sulfate, anhydrous lactose,
carnauba wax, colloidal silicon dioxide, corn starch, D&C
Yellow #10 Aluminum Lake, FD&C Yellow #6 Aluminum
Lake, gelatin, iron oxide, iron oxide black, iron oxide yellow
(iron oxide ochre), magnesium stearate, microcrystalline
cellulose, polyethylene glycol (PEG) 400, polyvinyl acetate
phthalate, povidone, shellac, sodium starch glycolate, stearic
acid, sugar, talc, titanium dioxide
Questions or comments? 1-888-333-9792
GENTLE
LAXATIVE
Bisacodyl Tablets, USP 5 mg
overnight relief
200 tablets
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68210-3120 | 68210-3120-1 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2a81da02-e6ab-ff1e-e063-6294a90abf72 | 6d3d187b-bdac-4bbc-a048-839dd057ea38 | 2024-12-30 | Warnings | 6d3d187b-bdac-4bbc-a048-839dd057ea38 |
Adverse event summaries are temporarily unavailable. Other product information remains available.